Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salmeterol Urine Sample Generation for Anti-Doping
NCT04195867Phase 1Completed
- Sponsor
- Parc de Salut Mar
- Start
- Nov 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of salmeterol in asthma and chronic obstructive pulmonary disease (COPD), sponsored by Parc de Salut Mar. Primary endpoint: Changes in urine concentration of salmeterol. Started Nov 2018; status: completed.
02
Drugs
salmeterol
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT04195867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04195867.